長崎Edwards
|
|
|
- しょうこ けいれい
- 7 years ago
- Views:
Transcription
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47 BMJ 1997; 315: Esophageal Doppler FTc > 0.35
48 Protocol
49
50 (1997) Esophageal Doppler GDT
51 Anesthesiology 2002; 97: Major surgery Esophageal Doppler FTc >0.35
52
53
54
55
56
57 GDT PONV LOSGDT5 vs 7
58 6% hetastarchgoal directed fluid administration
59
60 Year Journal Device Goal 2007 Crit Care HandmadePPV PPV <10% 2008 Int J Surg LiDCO cft > Diseases of colon ESO D PVI < 13% 2010 A&A PVI CI > 2.5, SVV < Crit Care Flo Trac CI > EJA Flo Trac 15ml/kg vs 40 ml/kg 2010 Obase Surg SV maximization 2010 Crit Care Flo Trac SV increase < 10% 2011 A&A Mashimo Raibow ESO D PPV < 13% 4ml/kg/hr vs 12 ml/kg/hr 2011 Crit Care LiDCO SV increase < 10% 2012 BJA ESO D SV increase < 10% 2012 BJA ESO D SV increase < 10% 2013Acta Anaesth Scand LiDCO SV increase < 10% 2013 BJA ESO D SV increase < 10% 2013 J Clin Monit Comp Flo Trac SV increase < 10% 2013 BJS ESO D SV increase < 10%
61 Flo Trac LiDCO SV increase < 10%
62 Year Journal N Patients Outcome 2007 Crit Care 33 High risk surgery LOS Int J Surg 50 Emergency abdominal surgery Renal function Diseases of colon 64Laparoscopic colectomy Colloid is worse 2010 A&A 82 Major abdominal surgery PVI less fluid 2010 Crit Care 60 High risk abdominal suregry LOS +, Complication less 2010EJA 57 Peripheral Vascular Surgery No difference 2010 Obase Surg 100 Bariatic surgery 2010 Crit Care 40 Total Hip (regional) Less complication 2011 A&A 25 Major colorectal suregry PVI can predict FR 2011 Crit Care 88 High risk major surgery Restricted is better 2012BJA 150Elective colorectal suregry No difference 2012 BJA 179 Colorectal surgery No difference 2013Acta Anaesth Scand 70Abdominal aortic surgery No dofference 2013 BJA 50 Ovarina Cancer surgery HES is better 2013 J Clin Monit Comp 64High risk surgery Almost no difference 2013 BJS 85 Colorectal surgery No difference
63 Year Jorunal Device Bolus Fluid 2007 Crit Care HandmadePPV HES 2008 Int J Surg LiDCO HES 2009 Diseases of colon ESO D HES or LR 2010 A&A PVI HES 2010 Crit Care Flo Trac Colloid 2010 EJA Flo Trac HES 2010 Obase Surg 2010 Crit Care Flo Trac HES 2011 A&A Mashimo Raibow ESO D HES 2011 Crit Care LiDCO Gelatin 2012 BJA ESO D HES 2012 BJA ESO D HES 2013Acta Anaesth Scand LiDCO HES 2013 BJA ESO D HES vs crystaloid 2013 J Clin Monit Comp Flo Trac HES 2013 BJS ESO D HES
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
l t a2 b c f g or t a2 b c f a2 b c f or l t a2 b c f g t a2 b c f g l t
o r lt LONDON 70120-770-361 1 BOOK a2 b c f a2 b c f g t MAP -C2 l t a2 b c f g or t a2 b c f a2 b c f or l t a2 b c f g t a2 b c f g l t a2 b c f a2 b c f g a2 b c f a2 b c f o a2 b c f g a2 b c f lr
2
1 2 3 4 5 6 7 2007 30,870 2008 32,426 2009 34,971 13,000 8 9 http://www.hokkaido-marathon.com/volunteer/ http://www.hokkaido-marathon.com/volunteer/leader.html 2009 / http://www.shonan-kokusai.jp/archives/volunteer/
... 3... 3... 3... 3... 4... 7... 10... 10... 11... 12... 12... 13... 14... 15... 18... 19... 20... 22... 22... 23 2
1 ... 3... 3... 3... 3... 4... 7... 10... 10... 11... 12... 12... 13... 14... 15... 18... 19... 20... 22... 22... 23 2 3 4 5 6 7 8 9 Excel2007 10 Excel2007 11 12 13 - 14 15 16 17 18 19 20 21 22 Excel2007
http://banso.cocolog-nifty.com/ 100 100 250 5 1 1 http://www.banso.com/ 2009 5 2 10 http://www.banso.com/ 2009 5 2 http://www.banso.com/ 2009 5 2 http://www.banso.com/ < /> < /> / http://www.banso.com/
n=360 28.6% 34.4% 36.9% n=360 2.5% 17.8% 19.2% n=64 0.8% 0.3% n=69 1.7% 3.6% 0.6% 1.4% 1.9% < > n=218 1.4% 5.6% 3.1% 60.6% 0.6% 6.9% 10.8% 6.4% 10.3% 33.1% 1.4% 3.6% 1.1% 0.0% 3.1% n=360 0% 50%
【知事入れ版】270804_鳥取県人口ビジョン素案
7 6 5 4 3 2 1 65 1564 14 192 193 194 195 196 197 198 199 2 21 22 23 24 1.65 1,4 1.6 1,2 1.55 1, 1.45 6 1.5 8 1.4 4 1.35 1.3 2 27 28 29 21 211 212 213 214 6 5 4 3 2 1 213 218 223 228 233 238 243 248 253
日本皮膚科学会雑誌第121巻第14号
World J Surg Burns Burns JTrauma Lancet Lancet Surg Gynecol Obste J Burn Care Rehabil BMJ Pediatr Emerg Care The Treatment of Burns Burns, A Team Approach Surg Gynecol Obstet NEnglJMed J Burn Care Rehabil
JA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
項 目
1 1 2 3 11 4 6 5 7,000 2 120 1.3 4,000 04 450 < > 5 3 6 7 8 9 4 10 11 5 12 45 6 13 E. 7 B. C. 14 15 16 17 18 19 20 21 22 23 8 24 25 9 27 2 26 6 27 3 1 3 3 28 29 30 9 31 32 33 500 1 4000 0 2~3 10 10 34
Surgical AKI non-cardiac surgery
Surgical AKI in non-cardiac surgery 慈恵 ICU 勉強会 周術期 AKI の文献の中で 心臓外科手術との関連について調べた論文は数多くあるが 非心臓外科手術と AKI について調べた論文は少ない 11.3% (21) 88.7% (165) 心臓外科 その他 周術期 AKI の機序 術前リスクファクター周術期増悪因子 手術侵襲 周術期 AKI 発症 Miller
FR 34 316 13 303 54
FR 34 316 13 303 54 23 ( 1 14 ) ( 3 10 ) 8/4 8/ 100% 8 22 7 12 1 9 8 45 25 28 17 19 14 3/1 6/27 5000 8/4 12/2930 1 66 45 43 35 49 25 22 20 23 21 17 13 20 6 1 8 52 1 50 4 11 49 3/4/5 75 6/7/8 46 9/10/11
日本臨床麻酔学会 vol.37
219 日本臨床麻酔学会第 35 回大会シンポジウム日臨麻会誌 Vol.37 No.2, 219 224, 2017 Goal-Directed Therapy( 目標指向型輸液療法 ) の実践 ~ 国内外の実例を交えて ~ ERAS 時代の目標指向型輸液療法 (Goal-Directed Therapy) *1 松崎孝 *2 森松博史 [ 要旨 ] 周術期の輸液管理は重要で, 脱水と輸液過剰は術後合併症の点で有害である.
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
●70974_100_AC009160_KAPヘ<3099>ーシス自動車約款（11.10）.indb
" # $ % & ' ( ) * +, -. / 0 1 2 3 4 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y " # $ % & ' ( ) * + , -. / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B
untitled
280 200 5 7,800 6 8,600 28 1 1 18 7 8 2 ( 31 ) 7 42 2 / / / / / / / / / / 1 3 (1) 4 5 3 1 1 1 A B C D 6 (1) -----) (2) -- ()) (3) ----(). ()() () ( )( )( )( ) ( ) ( )( )( )( ) () (). () ()() 7 () ( ) 1
グリコカリックス モデルから 導 く 敗 血 症 に 対 する 輸 液 戦 略 ~スターリングの 式 はもう 古 い~ 慈 恵 ICU 勉 強 会 2012/9/11 腎 臓 高 血 圧 内 科 白 井 泉 目 次 1スターリングの 法 則 と 輸 液 の 分 布 2SAFEスタディーの 不 思 議 ~ 輸 液 の 分 布 の 実 際 ~ 3スターリングの 法 則 の 矛 盾 とグリコカリックス
untitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J
Rinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
untitled
186 17 100160250 1 10.1 55 2 18.5 6.9 100 38 17 3.2 17 8.4 45 3.9 53 1.6 22 7.3 100 2.3 31 3.4 47 OR OR 3 1.20.76 63.4 2.16 4 38,937101,118 17 17 17 5 1,765 1,424 854 794 108 839 628 173 389 339 57 6 18613
untitled
1. 3 14 2. 1 12 9 7.1 3. 5 10 17 8 5500 4. 6 11 5. 1 12 101977 1 21 45.31982.9.4 79.71996 / 1997 89.21983 41.01902 6. 7 5 10 2004 30 16.8 37.5 3.3 2004 10.0 7.5 37.0 2004 8. 2 7 9. 6 11 46 37 25 55 10.
2
1 2 119 119 5 500 1 30 102 1 113 3 4 120 2 3 113 5 230 1 1 3 4 5 6 7 8 1 support@kansen.sakura.ne.jp 2 9 3 ( ) 10 11 12 4 1. 2. 3. 4. 13 5 14 15 16 17 18 19 [ ] [ ] 20 [ ] [ ] [ ] 21 22 [ ] 23 < > < >
54 Ⅱ 2012 CI CI ADL 3 2 Ⅲ 5cm 1 : : : : 2014 5 1 CI Open technique 12 1 2 CT 2 2 5
91 53 57 2015 1) 1) 1) 1) 1) 1) 1) 1) 2) 2) 1) 3) 2014 10 212014 10 24 covering ileostomy 2012 2014covering ileostomy 5 2 Key words: Ⅰ covering stoma fecal diversion covering ileostomyci 1 3 1) 2) 3) Tetsutaro
1 1 2 65
3 3 2000 6 14 2 30 4 2 1 1 2 65 1!?? < > 3 2 2 100 19 19 100 100 100 < > 19 2 2 2 2 < > 2000 2000 50 1945 5 50 1945 5 45 20 20 4 1945 4 5 5 5 100 50 20 5 2 20 5 20 5 5 6 20 6 19 5 5 6 5 6 2 20 6 21
胆石症
,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
38-5 History/柴
V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) V o l. 3 8 N o. 5 ( 2 0 0 6 ) Jpn Heart J Acta Med Scand Z Kreislaufforsch Jpn
Journal Club
Journal Club Passive Leg Raising は輸液反応性の指標となるか? 2016/07/12 東京ベイ浦安 市川医療センター 初期研修医 2 年目李紀廉 本日の論文 一般的に血管内 volume の指標と して我々が用いているものは 輸液反応性の指標である 輸液反応性とは 輸液負荷により心拍出量が増えるか 輸液負荷は心拍出量を増やすために最も行われる手法であるが 不必要な輸液は合併症
AVIC-HRV22
AVIC-HRV22 153-8654 1-4-1 2006 < KSKZF > < 06H00000 > < CRA3945-B > q w e r 2 3 4 5 6 7 z x c v b 1 n 0., m 3 2 8 z x c v b n m,. 0 1 2 3 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 1 2 25 26 3 27 1
2
1 2 3 4 5 6 7 8 9 10 11 12 Character ASCII Code Description \ [092] backslash / [047] forward slash : [058] colon * [042] asterisk? [063] question mark " [034] double quotes < [060] less than > [062] greater
がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性
2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
11) Kumar, R., et al.: Lancet, 1 : 90, 1973. 12) Baek, S. M., et al.: Ann. Surg., 177: 253, 1973. 13) Beak, S. M., et al.: Ann. Surg., 178 : 605, 1978. 14) Beak, S. M., et al.: Surgery, 77: 632, 1975.
NST/ASSESSMENT NETWORK NST/ASSESSMENT NETWORK Nutrition Support Journal 5 Nutrition Support Journal 5 NS DIETITIAN Nutrition Support Journal 5 NS ADMINISTRATION NS PHARMACIST NS PHARMACIST Nutrition
Quality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-c
Quality of Life of Outpatients Treated with Low Anterior Resection or Anterior Resection for Colorectal Cancer orrelation Between Dyschezia and Self-completed QOL Questionnaire- Nami Imai *1, Yoshihiro
日本皮膚科学会雑誌第121巻第12号
Geriatrics Akt Dermato Eur J Vasc Endovasc Surg Ann R Coll Surg Engl Br J Surg Cochrane Database Syst Rev Cochrane Database Syst Rev Cochrane Database Syst Rev Cochrane Database Syst Rev Int wound J Eur
特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに sepsis RE- DOXS Ⅱ 重症患
143 特 集 conditionally essential amino acid, グルタミンジペプチド (Glutamine dipeptide), 多臓器不全 Ⅰ はじめに 1980 2013 sepsis RE- 173 8605 2 11 1 Ⅱ 重症患者における生体内でのグルタミンの役割 1950 Eagle 1 1970 2 1/3 40 50 144 30 conditionally
, 183
182 , 183 < > < > 184 < > < > < p. > 185 < > < > 186 < p. > < p. > < p. > < p. > < p. > < p. > < p. > 187 < p. > 188 < p. > 189 190 A B A B A B A
Ⅱ Hb 4.1g/dl S LST G S ESD 10 S S 4 4 S D mL tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S tub1 tub2 SS
92 183 188 2016 1 1,2) 1) 1) 1) 1) 1) 3) 1) 2016 2 1 2016 3 11 84 S 2011 10 S 30 40 2 tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S 30 30 2 tub1 tub2 SS ly0 v0 PM0 DM0 N0 0/19 stage tub1 M ly0 v0 HM0 VM0 stage
untitled
1 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 2 ( ) 1 ( ) ( ) ( ) ( ) 3 ( ) a b ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 4 ( ) ( ) ( ) ( ) ( ) ( ) < > 5 a b c d ( ) ( ) ( ) ( ) ( ) 18 73 ( ) ( ) a b 6 6 c ( ) (
ACCESS入門編
ACCESS () / 255 65535 0 255-32768 32767 15 4 1 Yes/No OLE Yes=-1 NO=0 OK Like AND *[ ]* Like *[ ]* Like >= =40 40 OR 1 OR AND 2000 2 2 AND 2 OK CTRL SHIFT IME 1 IME [1] [2]2
untitled
( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m
16 23 270 5 1 2 3 1 2 3 1 2 3 6 5 54 44 9 9 4,000 118 7 5 JA 8 1 1 2 16 48,000 1 1 1 1 2 2 3 1, 312. 87 4 5 10 3 31 6 10 4 25 7 3 1 2 8 2 495. 84 1 296. 49 2 199. 35 1 124. 62 54. 50 28. 80 34. 17 54.
TOKYO Bay CAR FERRY 142 143
140 141 TOKYO Bay CAR FERRY 142 143 145 144 146 147 149 148 150 1 2 3 4 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ 151 153 152 155 154 156 157 159 158 161 160
IPDF.qxd
127 Single Incision Laparoscopic Surgery for the Elderly with Colon Cancer Aged 85 or Older in Our Hospital Tsuyoshi Takagi, Hiroki Kobayashi, Syouji Hirajima and Kanehisa Fukumoto Department of Surgery,
医 事 法 山口大法医 藤宮龍也
2 ( If anything can go wrong, it will. Things go wrong in batches. MiniMax (mini) (max) ( ) - 134 135 105 149 1) 2) 3) cf. cf. - 160-214 cf. - 211 209,210-204 vs 35 37-19 217 218-202 203 cf. - ( ) 104
日本皮膚科学会雑誌第122巻第2号
J Dermatol Sci Vitam Horm NEnglJMed Lancet J Clin Invest Antitoxid Redox Signal Diabetes Metab Res Rev Diabetes Care Diabet Med Diabetes care Diabetes Care J Foot Ankle Surg Wound Repair Regen Lancet Foot
日本臨床麻酔学会 vol.31
81 81 日本臨床麻酔学会第 29 回大会シンポジウム日臨麻会誌 Vol.31 No.1, 81 90, 2011 循環モニター : 非侵襲的モニターは侵襲的モニターを超えられるか? フロートラックシステムの有用性の検討 福田 * 功 [ 要旨 ] フロートラックシステムは FloTrac t m sensor と Vigileo t m monitor からなるキャリブレーションを必要としない連続的動脈圧心拍出量モニター
1) linisely, M. H. : Postburn Pathologic circulatory Physiology. F. A. Davis Co. philadelphia 1962, 2) James, G. W. et. al. : The anemia of thermal injury : Erythropoiesis and hemoglobin metabolism studied
Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )
ICT 5,293 (2012 3 31 ) http://www.nttcom.co.jp/employ/recruit/ 4. IT IT / / IT / / . BB http://recruit.softbank.jp/graduate/ 3-7-1 28 29 URL.http://www.nliro.or.jp 2014 . ( ) 10 ( ) < > / < > . ( )
2
1 2 10 14 945 3000 2012 3 10 4 5 6 7 8 9 10 11 12 2011 11 21 12301430 (1215 ) 13 6 27 17 () ( ) ( ) (112360) 2 (1157) (119099) ((11861231) )( ) (11641205) 3 (1277) 3 4 (1558) (1639)() 12 (1699)( ) 7 (1722)
02
54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148
92 adenocarcinoma SE ly2 v2 n0 pstage KRAS XX XX 2 1 mfolfox6 l-lv 300 / L-OHP 130 / 5-FU 600 / 5-FU 3,600 / FU/LV de Gramont
92 91 95 2016 5-FU 1 1) 2) 3) 2) 2016 1 5 2016 3 4 FOLFIRI Bevacizumab Bev 5-FU NH3 1 NH 3 5-FU NH 3 Key words: 5-FU : NH 3 orotate phosphorylase OPRT thymidylate synthase TS dihydropyrimidine dehydrogenase
00 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0..0..........0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0... 0...... 0... 0 0 0 0 0 0..0 0... 0 0 0 0 0.0.....0.
BEE (basal energy expenditure) REE (resting energy expenditure) nprq (nonprotein respiratory quotient) TSF (triceps skinfold thickness) AMC (arm muscle circumference) Alb (albumin) PA (prealbumin) Tf (transferrin)
merci2013_p00_35.indd
00 02 04 05 06 08 09 10 11 12 13 14 15 16 17 18 19 20 22 24 25 26 27 28 29 30 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 54 55 56 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 74 75
スライド 1
1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00
Microsoft Word - 「黄砂とその健康影響について」小冊子180323版
...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html
7) G. N., A. A. Sondore et al.: The Use of Hyperbaric Oxygenation in Intensive Therapy of Patients with Liver Damage. VI Int. Cong. HBO Medicine, Moscow, Sept 2 `6:341, 1981 8) J. J. Moder, M. D.: Phagocytic
AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol
AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urology, Kumamoto University College of Medicine (Director:
Microsoft Word - 倫理 第40,43,45,46講 テキスト.docx
6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11
日本職業・災害医学会会誌第51巻第1号
内野ら 下腿骨骨折におけるハイブリッド創外固定器の有用性 31 図 2 軟部組織損傷程度と機能成績 Gustilo IIIB 以上の開放骨折では Gustilo IIIA 以下の開放骨折 及び皮下骨折よりも明らかに機能低下が認められた 図 1 年齢と機能成績 60 歳未満の若年者の方が明らかに良好な成績を示した a b c 図 3 a Gustilo Type IIIB b, c AO 分類 Type
不良債権問題の基本的な考え方
2002 10 11 10 90 1 RCC 2 3 1 2 3 1 2 3 4 4 5 4 5 5 6 0.7 0.1 6 6 7 7 7 8 ABS RCC RCC 9 10 11 19801986 1990 19921994 19922001 12 1985 13 2000 2001 2000 20052003 1995 SFAS121 IAS 1998 IAS36 1993
2 KH Coder KH Coder KH Coder KH Coder
Keywords : 1 2 KH Coder KH Coder KH Coder KH Coder 2.1 KH Coder 1 ........,,,..... .. 2 - - - - - - - - - - - - 2.2 3, ......... - - - - - - 4 3 3.1.. 1 - / - - - - - 2 - ....... a . ... 3.2 < >, Sunday
- 1 - - 2 - 320 421 928 1115 12 8 116 124 2 7 4 5 428 515 530 624 921 1115 1-3 - 100 250-4 - - 5 - - 6 - - 7 - - 8 - - 9 - & & - 11 - - 12 - GT GT - 13 - GT - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - -
38
3 37 38 3.1. 3.1.1. 3.1-1 2005 12 5 7 2006 5 31 6 2 2006 8 10 11 14 2006 10 18 20 3.1-1 9 00 17 3 3.1.2. 3.1-2 3.1-1 9 9 3.1-2 M- M-2 M-3 N- N-2 N-3 S- S-2 S-3 3.1.2.1. 25 26 3.1.2.2. 3.1-3 25 26 39 3.1-1
Post-Traumatic Osteolysis of the Distal End A Case of Post-Traumatic Osteolysis of the Distal End of the Clavicle by G. Kinoshita, M. Maeda, H.Takaiwa
Post-Traumatic Osteolysis of the Distal End A Case of Post-Traumatic Osteolysis of the Distal End of the Clavicle by G. Kinoshita, M. Maeda, H.Takaiwa and K. Nakano Department of Orthopaedic Surgery, Hyogo
Mix*: 2 bilateral Syme's amputation, 3 Syme's-B/K, 1 Syme's-A/K 1 bilateral through knee, 1 A/K through hip 2. Kegel, B., Carpenter, M. L. and Burgess, E. M.: Functional Capabilities of Lower Extremity
4.11 4 55 4.12 11 56 4.13 0 57 4.14 1 58 4.15 4 59 4.16 11 60 5 5.1 5.1 5.2 1 (1983) Q = K A I v = Q / A = K I v = v / o n o Q A L 3 T -1 I : K : LT -1 v LT -1 v LT -1 o n o 61 (3) 5.3 1 5.1 K=10-1 10-3
untitled
260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000
8 2 ( 55 ) 1 2 : 8 1 19 ( ) : 4F 7 [18:30]~[21:00] 3 : ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
![8 2 ( 55 ) 1 2 : 8 1 19 ( ) : 4F 7 [18:30]~[21:00] 3 : ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )](/thumbs/42/22902827.jpg "8 2 ( 55 ) 1 2 : 8 1 19 ( ) : 4F 7 [18:30]~[21:00] 3 : ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )")
8 1 ( 54 ) 1 2 : 8 1 9 ( ) : [18:40]~[21:10] 3 : ( ) ( ) ( ) ( ) ( ) [ ]( ) [ ]( ) ( ) ( ) 8 2 ( 55 ) 1 2 : 8 1 19 ( ) : 4F 7 [18:30]~[21:00] 3 : ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 8 3 ( 56 ) 1 : 8 2
1 2 3 6 10 < > 13 16 16 4 17 13 00 15 30 5
2004 16 3 23 q 4 21 r 1 2 3 6 10 < > 13 16 16 4 17 13 00 15 30 5 13 2 2 16 4 4 17 3 16 3 1 16 3 2 905 1438 1201 1205 1210 70 1812 25 1635 1654 3 44 47 10 10 911.18-R 1193 34 1652 4 911.107-H 1159 1685
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Journal Club Surviving Sepsis Campaign Guideline 2016 2017/02/14 東京ベイ 浦安市川医療センター救急集中治療科有野聡 Crit Care Med 2017; 3:00 00 背景 2002 年 The Surviving Sepsis Campaign (SSC) 29470 人の観察研究では死亡率減 (odds ratio, 0.96;
